traber jörg gispen (22 risultati)

gebundene Ausgabe. Condizione: Gut. 317 Seiten Der Erhaltungszustand des hier angebotenen Werks ist trotz seiner Bibliotheksnutzung sehr sauber. Es befindet sich neben dem Rückenschild lediglich ein Bibliotheksstempel im Buch; ordnungsgemäß entwidmet. Leichte altersbedingte Anbräunung des Papiers. In ENGLISCHER Sprache. Sprache: Englisch Gewicht in Gramm: 780.

Softcover. 270 p. Good condition. Reading pages are clean and without markings. Light signs of storage and use. Spine edge slightly bumped. Book corners slightly rubbed. Cover lightly stained. Otherwise decent copy. 9783794513369 Sprache: Englisch Gewicht in Gramm: 505.

Senile Dementia of the Alzheimer Type. Early Diagnosis, Neuropathology and Animal Models (Advances in Applied Neurological Sciences, 2). Large Index. Wth 118 Figs. Fine HC, like new, no DJ. 376 S. ISBN 0387157123.

Condizione: Good. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library, so some stamps and wear, but in good overall condition. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.

Hardcover. Condizione: Very good. Advances in Applied Neurological Sciences 2. ix, 376 p. 25 cm. B&w figures and tables. Blue cloth. Light wear to extremities. Ink signature on front free endpaper. Proceedings of the Second International Tropon-Bayer Symposium on Aging of the Brain. Topics include: cognitive function in normal aging; cognitive deficits in Parkinson's Disease; depression vs. dementia; early diagnosis of dementia; brain plasticity and trophic factors; animal models.

Aging of the Brain. Proceedings of the First International Tropon Symposium on Brain Aging, held in Cologne, Federal Republic of Germany, on November 16-18, 1982. HC, no DJ - vg. 317 S. ISBN 044480546X Proceedings of the First International Tropon Symposium on Brain Aging, held in Cologne, Federal Republic of Germany, on November 16-18, 1982.

317 Seiten. Mit Abbildungen. Hardcover. Ordnungsgemäß aus einer Universitäts-Bibliothek ausgesondert (Stempel, Signatur). Guter Zustand. Sprache: Englisch Gewicht in Gramm: 790.

Hardcover. Condizione: Good. 1st Edition. 376 p; 118 Fig. [ADVANCES IN APPLIED NEUROLOGICAL SCIENCES ; 2]. Buch.

Hardcover. Condizione: Near Fine. Hardback in near fine condition.

Condizione: Gut. Oxford, Elsevier, 1983. 317 S. Olwd. ( Einband leicht fleckig, Kap gestaucht, Name auf Vs. ) Ich versende mit der Deutschen Post (Büchersendung) und der DHL (Pakete). Die Lieferzeit ist abhängig von der Versandart und beträgt innerhalb Deutschlands 3-5 Tage, in der EU 5 - 14 Tage. Sprache: Deutsch.

482 Ehemaliges Bibliotheksex. m. Stempel u. Sign. Nur leichte Lager- und Gebrauchsspuren, guter und gepflegter Zustand. --- Wir haben tausende weitere Titel aus den Bereichen Psychologie und Psychiatrie im Bestand, sprechen Sie uns an. --- Ex-library book with stamps and signature. Only slight traces of use- and shelf wear, good and clean condition. --- We have thousands of titles dealing with pychiatric and psychological studies in stock, feel free to contact us. 0897668790 Sprache: Englisch Gewicht in Gramm: 530.

Condizione: New.

Condizione: good. Befriedigend/Good: Durchschnittlich erhaltenes Buch bzw. Schutzumschlag mit Gebrauchsspuren, aber vollständigen Seiten. / Describes the average WORN book or dust jacket that has all the pages present.

Condizione: New. In.

paperback. Condizione: Very Good. Very Good. book.

Paperback. Condizione: Brand New. reprint edition. 392 pages. 9.60x6.60x0.90 inches. In Stock.

Taschenbuch. Condizione: Neu. Senile Dementia of the Alzheimer Type | Early Diagnosis, Neuropathology and Animal Models | Jörg Traber (u. a.) | Taschenbuch | xii | Englisch | 2011 | Springer | EAN 9783642706462 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Taschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Society is showing increasing concern for disorders related to aging that lead to a loss of brain function. In view of the enormous proportion of elderly people in our society today, brain aging is more than ever subject to challenge to us all, not only politicians and health authorities, but every individual who is confronted with the difficult situation of watching the mental powers of apparently healthy elderly friends, neighbours, or relatives fail, often with alarming rapidity. This challenge is directed especially toward us scientists. As one of our colleagues succinctly put it 2 years ago at the close of our First International Symposium on Brain Aging: 'Do something. We are not dealing here with just another disease; we are concerned with human dignity. ' More than any statistics, these words convinced me that Tropon's decision to leave the field of classic CNS pharmacology and move into the field of gerontopsychopharmacology was the right one, even though we knew that success would be uncertain and that, even if it finally comes it will be many years hence. At this point, let me add a personal comment: each one of us is judged by his or her own success. We live in a competitive society where success counts. This applies not only to the businessman, but also to the scientist, in particular, to those in industry.

Paperback. Condizione: Like New. Like New. book.

Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Society is showing increasing concern for disorders related to aging that lead to a loss of brain function. In view of the enormous proportion of elderly people in our society today, brain aging is more than ever subject to challenge to us all, not only politicians and health authorities, but every individual who is confronted with the difficult situation of watching the mental powers of apparently healthy elderly friends, neighbours, or relatives fail, often with alarming rapidity. This challenge is directed especially toward us scientists. As one of our colleagues succinctly put it 2 years ago at the close of our First International Symposium on Brain Aging: 'Do something. We are not dealing here with just another disease; we are concerned with human dignity. ' More than any statistics, these words convinced me that Tropon's decision to leave the field of classic CNS pharmacology and move into the field of gerontopsychopharmacology was the right one, even though we knew that success would be uncertain and that, even if it finally comes it will be many years hence. At this point, let me add a personal comment: each one of us is judged by his or her own success. We live in a competitive society where success counts. This applies not only to the businessman, but also to the scientist, in particular, to those in industry. 392 pp. Englisch.

Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Society is showing increasing concern for disorders related to aging that lead to a loss of brain function. In view of the enormous proportion of elderly people in our society today, brain aging is more than ever subject to challenge to us all, not only pol.

Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Society is showing increasing concern for disorders related to aging that lead to a loss of brain function. In view of the enormous proportion of elderly people in our society today, brain aging is more than ever subject to challenge to us all, not only politicians and health authorities, but every individual who is confronted with the difficult situation of watching the mental powers of apparently healthy elderly friends, neighbours, or relatives fail, often with alarming rapidity. This challenge is directed especially toward us scientists. As one of our colleagues succinctly put it 2 years ago at the close of our First International Symposium on Brain Aging: 'Do something. We are not dealing here with just another disease; we are concerned with human dignity. ' More than any statistics, these words convinced me that Tropon's decision to leave the field of classic CNS pharmacology and move into the field of gerontopsychopharmacology was the right one, even though we knew that success would be uncertain and that, even if it finally comes it will be many years hence. At this point, let me add a personal comment: each one of us is judged by his or her own success. We live in a competitive society where success counts. This applies not only to the businessman, but also to the scientist, in particular, to those in industry.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 392 pp. Englisch.